In what is described as the largest foreign takeover by a Japanese company, drug maker Takeda's $62 billion purchase of Shire Plc is now complete. The two companies generate a combined $30 billion annual revenue. Under the deal, Takeda acquired Shire's recently opened $1 billion immunoglobulin plasma fractionation plant in Covington, Georgia. The company is the site's fourth owner, having changed hands three other times since construction began in 2013.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!